Publicacións (93) Publicacións de ALBERT DELGADO-IRIBARREN GARCÍA-CAMPERO

2024

  1. Efficacy of delafloxacin alone and in combination with cefotaxime against cefotaxime non-susceptible invasive isolates of Streptococcus pneumoniae

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 158-162

  2. Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

  4. Respiratory syncytial virus infection in adults: Differences with influenza

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 62-68

2023

  1. Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types

    Antibiotics, Vol. 12, Núm. 1

  2. Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents

    PLoS ONE, Vol. 18, Núm. 3 March

  3. High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load

    International Microbiology, Vol. 26, Núm. 3, pp. 471-474

  4. Role of Hologic® Panther AptimaTM SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 516-518

  5. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

2022

  1. A Prospective Study of the Serological, Clinical, and Epidemiological Features of a SARS-CoV-2 Positive Pediatric Cohort

    Children, Vol. 9, Núm. 5

  2. Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain

    F1000Research, Vol. 11

  3. Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose

    Vaccines, Vol. 10, Núm. 9

  4. Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 538-543

  5. Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

    Frontiers in Oncology, Vol. 12

  6. Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects

    Journal of Infection, Vol. 85, Núm. 4, pp. 412-417

  7. Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection

    International Journal of Infectious Diseases, Vol. 114, pp. 85-87

  8. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

    IJID Regions, Vol. 4, pp. 10-16

  9. Usefulness of SARS-CoV-2 antigen test sample as input for SARS-CoV-2 RT-PCR analysis

    Journal of Medical Virology, Vol. 94, Núm. 4, pp. 1693-1695

2021

  1. Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study

    Journal of Clinical Virology, Vol. 143

  2. Comparative study of different SARS-CoV-2 diagnostic techniques

    Journal of Virological Methods, Vol. 298